R&D Advancing innovation in life sciences R&D and Quality: Towar... This year’s Veeva R&D and Quality Summit saw full-house attendance at the Marriott Auditorium Hotel in Madrid.
R&D Case Study: MHRA Following MHRA approval of a clinical trial, a study on Nuwiq, a recombinant FVIII therapy for the treatment of haemophilia A, can proceed.
Patients Sponsored Case Study: MHRA and AstraZeneca Agile, responsive regulation helps early breast cancer patients to benefit from a study to potentially improve survival outcomes.
Oncology Sponsored Case Study: MGI and Alacris Theranostics As World Cancer Day approached this year, the increasing focus on precision oncology continued apace.
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
